Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Sell
47
TRML Quote, Financials, Valuation and Earnings
Last price:
$47.98
Seasonality move
:
30.6%
Day range:
$47.98 - $47.98
52-week range:
$11.56 - $48.27
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
4.76x
Volume:
--
Avg. volume:
--
1-year change:
132.35%
Market cap:
$1.2B
Revenue:
--
EPS (TTM):
-$3.43
Analysts' Opinion
-
Consensus RatingTourmaline Bio, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 6 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $48.00, Tourmaline Bio, Inc. has an estimated upside of 0.04% from its current price of $47.98.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $48.00 representing 100% downside risk from its current price of $47.98.
Fair Value
-
According to the consensus of 7 analysts, Tourmaline Bio, Inc. has 0.04% upside to fair value with a price target of $48.00 per share.
TRML vs. S&P 500
-
Over the past 5 trading days, Tourmaline Bio, Inc. has underperformed the S&P 500 by -2.28% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Tourmaline Bio, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Tourmaline Bio, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Tourmaline Bio, Inc. reported revenues of --.
Earnings Growth
-
Tourmaline Bio, Inc. earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Tourmaline Bio, Inc. reported earnings per share of -$0.90.
Enterprise value:
993.6M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-11.51x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$43K
Return On Assets:
-28.74%
Net Income Margin (TTM):
--
Return On Equity:
-29.52%
Return On Invested Capital:
-29.5%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2024-06-30 | 2025-06-30 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -$609K | -$29K | -$43K | -$10K | -$12K | |
| Operating Income | -$48.4M | -$61M | -$102.4M | -$22M | -$26M | |
| EBITDA | -$49.4M | -$61M | -$102.4M | -$22M | -$26M | |
| Diluted EPS | -$15.72 | -$53.62 | -$3.44 | -$0.68 | -$0.90 | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $270.5M | $212M | $156.2M | $298.1M | $249.1M | |
| Total Assets | $272.8M | $220.9M | $159.1M | $344.8M | $269.3M | |
| Current Liabilities | $4.7M | $7.3M | $10.1M | $6.4M | $10.1M | |
| Total Liabilities | $5.5M | $10.2M | $10.7M | $6.5M | $10.1M | |
| Total Equity | $267.4M | $210.7M | $148.4M | $338.3M | $259.2M | |
| Total Debt | -- | $2.4M | $425K | $109K | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-06-30 | 2024-06-30 | 2025-06-30 | 2024-06-30 | 2025-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $13.8M | -$47.7M | -$86.3M | -$18M | -$20.3M | |
| Cash From Investing | -$45.5M | -$195.1M | $46.9M | -$10.1M | $16.3M | |
| Cash From Financing | $111.9M | $225.9M | $612K | -- | $54K | |
| Free Cash Flow | $16.1M | -$47.7M | -$86.3M | -$18M | -$20.3M | |
TRML
Sector
Market Cap
$1.2B
--
Price % of 52-Week High
99.4%
--
Dividend Yield
0%
--
Shareholder Yield
-0.14%
--
1-Year Price Total Return
132.35%
--
Beta (5-Year)
--
--
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$47.98
200-day SMA
Buy
Level
$29.15
Bollinger Bands (100)
Buy
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$47.98
Relative Strength Index (RSI14)
Buy
Level
89.34
ADX Line
Neutral
Level
0
Williams %R
Buy
Level
-100
50-day SMA
Buy
Level
$47.97
MACD (12, 26)
Buy
Level
10.67
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Neutral
Level
--
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (34.271)
Buy
CA Score
(Annual)
Level (0.1462)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (12.5097)
--
Piotroski F Score
(Annual)
Level (--)
Buy
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Stock Forecast FAQ
In the current month, TRML has received 1 Buy ratings 6 Hold ratings, and 0 Sell ratings. The TRML average analyst price target in the past 3 months is $48.00.
-
Where Will Tourmaline Bio, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Tourmaline Bio, Inc. share price will rise to $48.00 per share over the next 12 months.
-
What Do Analysts Say About Tourmaline Bio, Inc.?
Analysts are divided on their view about Tourmaline Bio, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Tourmaline Bio, Inc. is a Sell and believe this share price will drop from its current level to $48.00.
-
What Is Tourmaline Bio, Inc.'s Price Target?
The price target for Tourmaline Bio, Inc. over the next 1-year time period is forecast to be $48.00 according to 7 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.
-
Is TRML A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Tourmaline Bio, Inc. is a Hold. 6 of 7 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of TRML?
You can purchase shares of Tourmaline Bio, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Tourmaline Bio, Inc. shares.
-
What Is The Tourmaline Bio, Inc. Share Price Today?
Tourmaline Bio, Inc. was last trading at $47.98 per share. This represents the most recent stock quote for Tourmaline Bio, Inc.. Yesterday, Tourmaline Bio, Inc. closed at $47.98 per share.
-
How To Buy Tourmaline Bio, Inc. Stock Online?
In order to purchase Tourmaline Bio, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get TRML Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TRML
Sector
P/E ratio
--
--
PEG ratio
--
--
P/B ratio
4.76x
--
Price / LTM sales
--
--
Growth Metrics
TRML
Sector
Revenue growth
--
--
Earnings growth
-32.35%
--
Revenue (5-year growth)
--
--
Earnings forecast
-$0.98
--
Profitability
TRML
Sector
Profitability FY 2024
-$39K
--
Return on invested capital
-29.5%
--
Return on assets
-28.74%
--
Return on equity
-29.52%
--
Earnings Date
Last Earnings Date
Nov
13
Next Earnings Date
Dec
24
Estimated Next Earnings Date
Mar
25
Balance Sheet
TRML
Sector
Total cash
$239.2M
--
Short term investments
$227.8M
--
Total assets
$309M
--
Long term debt
$145K
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
60
ZBIO alert for Dec 23
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
Buy
54
UNF alert for Dec 23
UniFirst Corp. [UNF] is up 0.77% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
